Polyvalent Streptococcus Pneumococcal Vaccines Market Insights, Global Outlook and Forecast 2022-2028
The polyvalent streptococcus pneumoniae vaccine is a vaccine that mainly prevents pneumonia caused by Streptococcus pneumoniae. It contains a variety of serotypes that often cause streptococcus pneumoniae infection. After vaccination, it can effectively reduce the risk of pneumonia infection.
The latest research study released by Market IntelliX evaluates market size and forecasts of Polyvalent Streptococcus Pneumococcal Vaccines in global, including the following market information:
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Polyvalent Streptococcus Pneumococcal Vaccines companies in 2021 (%)
The global Polyvalent Streptococcus Pneumococcal Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
9-Valent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines include GlaxoSmithKline, LG Chem, Merck, Panacea Biotec, AstraZeneca, Pfizer, Shire, Pnuvax Incorporated and Serum Institute, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Polyvalent Streptococcus Pneumococcal Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Polyvalent Streptococcus Pneumococcal Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, by Type, 2021 (%)
9-Valent
13-Valent
23-Valent
Others
Global Polyvalent Streptococcus Pneumococcal Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospital
Community Clinics
Public Health Agencies
Others
Global Polyvalent Streptococcus Pneumococcal Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Polyvalent Streptococcus Pneumococcal Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines revenues share in global market, 2021 (%)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
GlaxoSmithKline
LG Chem
Merck
Panacea Biotec
AstraZeneca
Pfizer
Shire
Pnuvax Incorporated
Serum Institute
Shinogi
Shenzhen Kangtai Biological Products
SK Bioscience
Walvax Biotechnology
Eli Lilly
Abera
Sanofi
Genentech
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Polyvalent Streptococcus Pneumococcal Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Polyvalent Streptococcus Pneumococcal Vaccines Overall Market Size
2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size: 2021 VS 2028
2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales: 2017-2028
3 Company Landscape
3.1 Top Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market
3.2 Top Global Polyvalent Streptococcus Pneumococcal Vaccines Companies Ranked by Revenue
3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Companies
3.4 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Companies
3.5 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Polyvalent Streptococcus Pneumococcal Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Polyvalent Streptococcus Pneumococcal Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Markets, 2021 & 2028
4.1.2 9-Valent
4.1.3 13-Valent
4.1.4 23-Valent
4.1.5 Others
4.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
4.2.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
4.3.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2022
4.3.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2023-2028
4.3.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Community Clinics
5.1.4 Public Health Agencies
5.1.5 Others
5.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
5.2.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
5.3.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2022
5.3.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2023-2028
5.3.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
6.2.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
6.3.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2022
6.3.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2023-2028
6.3.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.4.3 US Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.4.4 Canada Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.4.5 Mexico Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.5.3 Germany Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.4 France Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.5 U.K. Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.6 Italy Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.7 Russia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.9 Benelux Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.6.3 China Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.4 Japan Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.5 South Korea Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.7 India Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.7.3 Brazil Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.7.4 Argentina Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.8.3 Turkey Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8.4 Israel Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8.6 UAE Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 LG Chem
7.2.1 LG Chem Corporate Summary
7.2.2 LG Chem Business Overview
7.2.3 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.2.4 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 LG Chem Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.3.4 Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Panacea Biotec
7.4.1 Panacea Biotec Corporate Summary
7.4.2 Panacea Biotec Business Overview
7.4.3 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.4.4 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Panacea Biotec Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.5.4 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.6.4 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 Shire
7.7.1 Shire Corporate Summary
7.7.2 Shire Business Overview
7.7.3 Shire Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.7.4 Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Shire Key News
7.8 Pnuvax Incorporated
7.8.1 Pnuvax Incorporated Corporate Summary
7.8.2 Pnuvax Incorporated Business Overview
7.8.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.8.4 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Pnuvax Incorporated Key News
7.9 Serum Institute
7.9.1 Serum Institute Corporate Summary
7.9.2 Serum Institute Business Overview
7.9.3 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.9.4 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Serum Institute Key News
7.10 Shinogi
7.10.1 Shinogi Corporate Summary
7.10.2 Shinogi Business Overview
7.10.3 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.10.4 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Shinogi Key News
7.11 Shenzhen Kangtai Biological Products
7.11.1 Shenzhen Kangtai Biological Products Corporate Summary
7.11.2 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.11.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.11.4 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Shenzhen Kangtai Biological Products Key News
7.12 SK Bioscience
7.12.1 SK Bioscience Corporate Summary
7.12.2 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.12.3 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.12.4 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.12.5 SK Bioscience Key News
7.13 Walvax Biotechnology
7.13.1 Walvax Biotechnology Corporate Summary
7.13.2 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.13.3 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.13.4 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.13.5 Walvax Biotechnology Key News
7.14 Eli Lilly
7.14.1 Eli Lilly Corporate Summary
7.14.2 Eli Lilly Business Overview
7.14.3 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.14.4 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.14.5 Eli Lilly Key News
7.15 Abera
7.15.1 Abera Corporate Summary
7.15.2 Abera Business Overview
7.15.3 Abera Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.15.4 Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.15.5 Abera Key News
7.16 Sanofi
7.16.1 Sanofi Corporate Summary
7.16.2 Sanofi Business Overview
7.16.3 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.16.4 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.16.5 Sanofi Key News
7.17 Genentech
7.17.1 Genentech Corporate Summary
7.17.2 Genentech Business Overview
7.17.3 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.17.4 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.17.5 Genentech Key News
8 Global Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity, Analysis
8.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity, 2017-2028
8.2 Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Polyvalent Streptococcus Pneumococcal Vaccines Supply Chain Analysis
10.1 Polyvalent Streptococcus Pneumococcal Vaccines Industry Value Chain
10.2 Polyvalent Streptococcus Pneumococcal Vaccines Upstream Market
10.3 Polyvalent Streptococcus Pneumococcal Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Polyvalent Streptococcus Pneumococcal Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Polyvalent Streptococcus Pneumococcal Vaccines in Global Market
Table 2. Top Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Product Type
Table 9. List of Global Tier 1 Polyvalent Streptococcus Pneumococcal Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 48. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. LG Chem Corporate Summary
Table 50. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 51. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 54. Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Panacea Biotec Corporate Summary
Table 56. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 57. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 60. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 63. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Shire Corporate Summary
Table 65. Shire Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 66. Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Pnuvax Incorporated Corporate Summary
Table 68. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 69. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Serum Institute Corporate Summary
Table 71. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 72. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Shinogi Corporate Summary
Table 74. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 75. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Shenzhen Kangtai Biological Products Corporate Summary
Table 77. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 78. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. SK Bioscience Corporate Summary
Table 80. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 81. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Walvax Biotechnology Corporate Summary
Table 83. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 84. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Eli Lilly Corporate Summary
Table 86. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 87. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Abera Corporate Summary
Table 89. Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 90. Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Sanofi Corporate Summary
Table 92. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 93. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Genentech Corporate Summary
Table 95. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 96. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 98. Global Polyvalent Streptococcus Pneumococcal Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 99. Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region, 2017-2022 (K Units)
Table 100. Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region, 2023-2028 (K Units)
Table 101. Polyvalent Streptococcus Pneumococcal Vaccines Market Opportunities & Trends in Global Market
Table 102. Polyvalent Streptococcus Pneumococcal Vaccines Market Drivers in Global Market
Table 103. Polyvalent Streptococcus Pneumococcal Vaccines Market Restraints in Global Market
Table 104. Polyvalent Streptococcus Pneumococcal Vaccines Raw Materials
Table 105. Polyvalent Streptococcus Pneumococcal Vaccines Raw Materials Suppliers in Global Market
Table 106. Typical Polyvalent Streptococcus Pneumococcal Vaccines Downstream
Table 107. Polyvalent Streptococcus Pneumococcal Vaccines Downstream Clients in Global Market
Table 108. Polyvalent Streptococcus Pneumococcal Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Polyvalent Streptococcus Pneumococcal Vaccines Segment by Type
Figure 2. Polyvalent Streptococcus Pneumococcal Vaccines Segment by Application
Figure 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Polyvalent Streptococcus Pneumococcal Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Polyvalent Streptococcus Pneumococcal Vaccines Revenue in 2021
Figure 9. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 19. US Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 33. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Polyvalent Streptococcus Pneumococcal Vaccines by Region, 2021 VS 2028
Figure 50. Polyvalent Streptococcus Pneumococcal Vaccines Industry Value Chain
Figure 51. Marketing Channels
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|